Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again By: Philadelphia Business Journal via Business Journals July 08, 2022 at 16:14 PM EDT Virpax is once again taking the OTC route for a new product candidate. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
